Skip to content

Internet Explorer is no longer supported by this website.

For optimal browsing we recommend using Chrome, Firefox or Safari.
Heart icon (animated) heart icon (static)
Our Businesses
Explore more Johnson & Johnson sites:
Switzerland
Page logo
Latest News

Johnson & Johnson to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
Johnson & Johnson to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

New Brunswick, NJ (August 22nd, 2023) -- Johnson & Johnson (NYSE: JNJ) will participate in the Morgan Stanley 21st Annual Global Healthcare Conference at the Sheraton New York Hotel in New York on Wednesday, September 13th. Joaquin Duato, Chairman of the Board and Chief Executive Officer and John Reed, Executive Vice President, Pharmaceuticals, R&D will represent the Company in a session scheduled at 10:10 a.m. (Eastern Time).

This conference call will be available to investors and other interested parties by visiting the Johnson & Johnson website at www.investor.jnj.com.

A webcast and podcast replay will be available approximately 48 hours after the live webcast.

  • Investor Contact:
    investor-relations@its.jnj.com

    Media Contact:
    media-relations@its.jnj.com
Back to top
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue